Results of a new study identify specific clinical characteristics linked to poor quality of life in patients with PAH.
FDA Grants Breakthrough Therapy Designation to Plozasiran for FCS
Don't Miss a Beat: Finerenone's Role in Heart Failure from ESC Congress Data
Study Finds Traditional Risk Scores Miss Most Patients at Risk of First Heart Attack
Diabetes Dialogue: First 10 Prices Announced from CMS Price Negotiations
ESC Congress Recap: High-Impact Clinical Trials, with Deepak Bhatt, MD, MPH, MBA
Aficamten in the Spotlight at ESC Congress, with Ahmad Masri, MD, MS